rheumatology
Medicines

Is targeting one cytokine better than another in treating COVID-19?

While it has been clear from early on in the COVID-19 pandemic that some severe cases are characterised by a hyperinflammatory state, targeting the cytokines involved in that inflammation has proven to be remarkably complicated. Now, new research shows that inhibition of IL-1, but not of IL-6, is associated with a reduction in mortality in ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic